Category: Workers Comp

523 posts found

FDA Approves New Opioid, Dsuvia

Five-to-ten times stronger than fentanyl, this drug is not for consumer use, and many claim it could worsen the opioid crisis.

This Month's Must Read

The Opioid Crisis: Our Defining Moment

Healthesystems’ clinical leaders comment on the collective responsibility of healthcare entities, providers, and legislators to increase efforts that will help stem opioid overprescribing, misuse and overdose.

Marijuana Updates

Midterm Marijuana Updates

More states allow for the legalization of recreational and medical marijuana, while others consider insurance reimbursement.

Clinical Insights

JAMA Examines Persistent Opioid Use in Workers’ Comp Patients

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.

Healthe Developments

Healthesystems at NWCDC 2018

Join our VP of Clinical Services on December 6th in Las Vegas for a presentation on value-based care in workers’ comp.

Medmonitor

DEA Reschedules Epidiolex

The marijuana-derived seizure drug now sits at schedule V, facing far fewer prescribing and dispensing restrictions.

This Month's Must Read

Dr. Silvia Sacalis Discusses Medication Red Flags with Risk & Insurance

Healthesystems’ VP of Clinical Services offers insight into prescriptions in workers’ comp claims that should raise concerns.

Legislation & Policy

New Jersey Bill Pushes for Medical Marijuana Reimbursement

Assembly No. 4505 may solidify precedence recently made by a judge from the Division of Workers’ Compensation.

Industry Trends

National Safety Council Issues Report on Workplace Fatigue

Common risk factors can increase worker fatigue, leading to more frequent workplace injuries and a loss of productivity.

Opioid Developments

Federal Opioid Reform Bill Signed into Law

With an enormous range of initiatives to prevent and treat opioid use disorder, the bill has officially been signed by the President.

Medmonitor

FDA Approves New Dosage for Opioid Dependence Therapy

Cassipa (buprenorphine and naloxone) sublingual film delivers a new dosage for the treatment of opioid dependence.

This Month's Must Read

Dr. Silvia Sacalis Discusses Polypharmacy with WC Magazine

Healthesystems’ VP of Clinical Services explains how too many drugs in a claim can cause health concerns, and what can be done to prevent them.

Legislation & Policy

FDA Reassesses Opioid Policies

The FDA is working to create new opioid prescribing practices and guidelines, while also shifting drug development priorities for pain medications.

Clinical Insights

CWCI Releases Polypharmacy Report

According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.

Opioid Developments

Massachusetts Study Links Occupation to Opioid Overdose Deaths

On average, construction workers are six times more likely to die from an opioid overdose death, more than any other occupation.

Prev 1 2 3 4 5 … 30 31 32 33 34 35 Next